“surface-oncology” Archives

in
Entry Author Date Location
Safety Signal Prompts Surface Oncology to Scale Down Lead Program 12/18/18 Boston
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
Surface Oncology’s Upsized IPO Reels In $108M for Lead Cancer Drug 04/18/18 Boston
Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More 03/30/18 National
Surface Oncology Plans IPO to Advance Clinical Tests of Cancer Drug 03/26/18 Boston
MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup 08/11/16 Boston
Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses 07/19/16 Boston
Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases 06/22/16 Boston
With New Execs, Sanofi Backing, ImmuneXcite Begins Clinical Push 03/30/16 Boston
Warp Drive, Surface, Bamboo Cut Deals on Eve of J.P. Morgan 01/11/16 Boston
Ever Fond of Options, Atlas Finds Potential Buyers For Rodin, Quartet 01/06/16 Boston
LabCentral Backers Planning $150M Venture Fund For Biotech Startups 10/21/15 Boston
East Coast Biotech Roundup: NY Bio, Synageva, Kadmon & More 05/08/15 New York
Ex-AstraZeneca Exec to Lead Surface’s “Next-Gen” Immuno-Oncology Plan 05/07/15 Boston
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
Surface Oncology Receives $35,000,000 Series A Round 01/09/15 Boston
One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash 01/08/15 National
Surface Oncology Raises $35M to Develop Cancer Immunotherapies 01/08/15 Boston
Page 1 of 1